AstraZeneca PLC (STO:AZN)
1,704.00
+9.50 (0.56%)
At close: Dec 5, 2025
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
5.81M SEK
Profits / Employee
939.18K SEK
Market Cap
2.65T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 47,256 |
| Getinge AB | 11,791 |
| Nolato AB | 5,837 |
| Elekta AB | 4,556 |
| Asker Healthcare Group AB | 4,030 |
| AddLife AB | 2,181 |
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
AstraZeneca News
- 2 days ago - Salesforce's Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement - Business Wire
- 2 days ago - FDA Streamlines Clinical Study Requirements, Impacting AstraZeneca (AZN) - GuruFocus
- 2 days ago - AstraZeneca (AZN) Could Benefit from FDA's Shift to Single Study Approval - GuruFocus
- 2 days ago - AstraZeneca (AZN) Set to Showcase Hematology Innovations at ASH 2025 - GuruFocus
- 2 days ago - AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH - Business Wire
- 3 days ago - AstraZeneca Shares Dip 0.7% Amid Patent Cliff Fears, But Pipeline Strength Fuels Long-Term Optimism - ABC Money
- 3 days ago - AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report - Benzinga
- 3 days ago - AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension - Nasdaq